—

Renibus Therapeutics, Inc.

Phase 3 Estimated

Veverimer

CKD

Countdown

358days

Phase 3 readout · ~ Jun 30, 2027 estimated

What's at stake Phase 3 trial results for Veverimer in CKD are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT07355062: Phase 3 trial, sponsor Renibus Therapeutics, Inc., drug Veverimer. Primary completion date 2027-06 (estimated).”

Add to calendar Post on X Reddit

Provenance